Acutaas Chemicals Plans Rs 350 Crore Investment Drive with Major Capex and Joint Venture Expansion

1 min read     Updated on 29 Jan 2026, 09:55 AM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Acutaas Chemicals announces Rs 350 crore investment plan including Rs 220 crore capex for FY26 and Rs 130 crore for Indochem joint venture. Battery chemicals business set for significant growth from Q1 FY27 with two new products launching by mid-FY27. Company targets over 25% annual revenue growth for next three years.

31206357

*this image is generated using AI for illustrative purposes only.

Acutaas Chemicals has unveiled a comprehensive investment strategy aimed at accelerating growth across its business segments. The chemical manufacturer plans to deploy Rs 350 crore across multiple initiatives, demonstrating its commitment to expanding operations and strengthening market presence.

Major Capital Investment Plan

The company's investment framework consists of two primary components designed to enhance operational capabilities and strategic partnerships.

Investment Component: Amount Purpose
FY26 Capital Expenditure: Rs 220 crore Operational expansion
Indochem Joint Venture: Rs 130 crore Strategic partnership
Total Investment: Rs 350 crore Combined initiatives

Battery Chemicals Business Expansion

The company's battery chemicals division is set for substantial growth beginning Q1 FY27. This segment represents a key focus area as the company positions itself to capitalize on the growing demand for battery-related chemical products. Two new products are scheduled for launch by mid-FY27, which are expected to drive significant business expansion in this vertical.

Aggressive Growth Targets

Acutaas Chemicals has established ambitious financial objectives for the coming years. The company aims to achieve over 25% annual revenue growth for the next three years, reflecting management's confidence in market opportunities and operational capabilities.

Growth Parameter: Target
Annual Revenue Growth: Over 25%
Duration: Next three years
Key Growth Driver: Battery chemicals segment
Product Launch Timeline: Mid-FY27

Strategic Timeline and Milestones

The company has outlined a clear roadmap for its expansion plans. The Rs 220 crore capital expenditure is earmarked for FY26, while the battery chemicals business growth is expected to commence from Q1 FY27. The introduction of two new products by mid-FY27 will serve as a catalyst for the anticipated revenue acceleration.

This comprehensive investment strategy positions Acutaas Chemicals for substantial growth across multiple business segments, with particular emphasis on the emerging battery chemicals market.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.78%+3.06%+24.31%+62.52%+91.68%+351.94%

Acutaas Chemicals Makes Q3 FY26 Earnings Call Recording Available to Investors

1 min read     Updated on 28 Jan 2026, 07:45 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Acutaas Chemicals Limited has made its earnings call recording from January 28, 2026, available to investors through its official website. The disclosure complies with SEBI regulations 30 and 46(2), following an earlier intimation submitted on January 22, 2026. The recording, held at 5.00 p.m. IST, can be accessed via the company's website, demonstrating the company's commitment to regulatory compliance and investor transparency.

31155327

*this image is generated using AI for illustrative purposes only.

Acutaas chemicals Limited has announced the availability of its earnings call recording to investors and stakeholders, following regulatory compliance requirements. The company held its earnings call on January 28, 2026, and has now made the recording accessible through its official website.

Regulatory Compliance and Disclosure

The earnings call recording has been made available in accordance with Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure represents a continuation of the company's regulatory obligations, following an earlier intimation about the earnings call that was submitted on January 22, 2026.

Parameter: Details
Call Date: January 28, 2026
Call Time: 5.00 p.m. IST
Website: www.acutaas.com
Prior Intimation: January 22, 2026

Access Information

Investors and stakeholders can access the earnings call recording through the company's official website. The recording has been made available through a dedicated download link, ensuring easy accessibility for all interested parties. The company has provided specific access details to facilitate investor engagement and maintain transparency in its communications.

Corporate Governance

The disclosure was formally communicated to both major stock exchanges where the company's shares are listed. Ekta Kumari Srivastava, Company Secretary & Compliance Officer, signed the regulatory filing, ensuring proper authorization and compliance with corporate governance standards. The communication was digitally signed on January 28, 2026, at 18:30:53 +05'30', demonstrating the company's commitment to timely and accurate regulatory reporting.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.78%+3.06%+24.31%+62.52%+91.68%+351.94%

More News on Acutaas Chemicals

1 Year Returns:+91.68%